A new application about 42923-79-5

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Computed Properties of C9H10N2O2, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 42923-79-5

New Advances in Chemical Research in 2021. In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 42923-79-5, name is 7-Nitro-1,2,3,4-tetrahydroisoquinoline, introducing its new discovery. Computed Properties of C9H10N2O2

The invention discloses a cobalt catalytic hydroformylation reaction synthesis carboxamide derivatives of the method, the method is that the amine compound with the formyl compound in the cobalt salt under the catalytic action of a one-pot reaction to produce the carboxamide derivatives; the reaction of raw materials and catalyst are cheap and easily obtained, and the reaction step and the operation is simple, with high selectivity, high yield, can be expands the quantity reaction and the like, and overcomes the reaction reagent toxicity in the prior art large, expensive catalyst, more reaction steps, more byproducts and the like. (by machine translation)

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Computed Properties of C9H10N2O2, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 42923-79-5

Reference:
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem